Inference for the existence of hormetic dose-response relationships in toxicology studies

Biostatistics

Volumn 17, Issue 3, 2016, Pages 523-536

  Kim, Steven B ^a   Bartell, Scott M ^b   Gillen, Daniel L ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b Ringgold Standard Institution Informatics   (United States)

Author keywords

Non parametric models

Indexed keywords

AVERAGING; DIAGNOSTIC TEST ACCURACY STUDY; HORMESIS; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TOXICOLOGY; BAYES THEOREM; HUMAN; PROCEDURES; THEORETICAL MODEL;

BAYES THEOREM; HORMESIS; HUMANS; MODELS, THEORETICAL; TOXICOLOGY;

EID: 84977178259     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxw004     Document Type: Article

References (28)

1. ARMITAGE, P. (1985). Multistage models of carcinogenesis. Environmental Health Perspectives 63, 195-201.
2. BEDRICK, E. J., CHRISTENSEN, R. AND JOHNSON, W. (1996). A new perspective on priors for generalized linear models. Journal of the American Statistical Association 91, 1450-1460.
3. BELZ, R. G. AND PIEPHO, H. (2012). Modeling effective dosages in hormetic dose-response studies. PLoS ONE 7(3), e33432.
4. BOWMAN, A., JONES, M. AND GIJBELS, I. (1998). Testing monotonicity of regression. Journal of Computational and Graphical Statistics 7, 489-500.
5. CALABRESE, E. J. (2001). The future of hormesis: where do we go from here?. Critical Reviews in Toxicology 31, 637-648.
6. CALABRESE, E. J. AND BALDWIN, L. A. (1997). A quantitatively-based methodology for the evaluation of chemical hormesis. Human and Ecological Risk Assessment: An International Journal 3, 545-554.
7. CALABRESE, E. J. AND BALDWIN, L. A. (2001). The frequency of u-shaped dose responses in the toxicological literature. Toxicological Sciences 62, 330-338.
8. CALABRESE, E. J. AND BALDWIN, L. A. (2003). The hormetic dose-response model is more common than the threshold model in toxicology. Toxicological Sciences 71, 246-250.
9. CALABRESE, E. J. AND COOK, R. R. (2005). Hormesis: how it could affect the risk assessment process. Human and Experimental Toxicology 24, 265-270.
10. CRUMP, K. S. (1996). The linearized multistage model and the future of quantitative risk assessment. Human and Experimental Toxicology 15, 787-798.
11. CRUMP, K. S. (2001). The regulatory implications of hormesis: is hormesis a universal phenomenon? Critical Reviews in Toxicology 31, 669-679.
12. DETTE, H., PEPELYSHEV, A. AND WONG, W. K. (2011). Optimal experimental design strategies for detecting hormesis. Risk Analysis 31(12), 1949-1960.
13. Environmental Protection Agency (2012). Benchmark dose technical guidance. EPA/100/R-12/001, Risk Assessment Forum, Environmental Protection Agency, Washington, DC, USA.
14. HALL, P. AND HECKMAN, N. E. (2000). Testing for monotonicity of a regression mean by calibrating for linear functions. Annals of Statistics 28, 20-39.
15. HANS, C. AND DUNSON, B. D. (2005). Bayesian inferences on umbrella orderings. Biometrics 61, 1018-1026.
16. HUNT, D. L. AND BOWMAN, D. (2004). A parametric model for detecting hormetic effects in developmental toxicity studies. Risk Analysis 24(1), 65-72.
17. HUNT, D. AND RAI, S. N. (2005). Testing threshold and hormesis in a random effects dose-response model applied to developmental toxicity data. Biometrical Journal 47(3), 319-328.
18. ISHWARAN, H. AND RAO, J. S. (2005). Spike and slab variable selection: frequentist and bayesian strategies. The Annals of Statistics 33(2), 730-773.
19. KIM, S. B., BARTELL, S. M. AND GILLEN, D. L. (2015). Estimation of a benchmark dose in the presence or absence of hormesis using posterior averaging. Risk Analysis 35(3), 396-408.
20. MATTSON, M. P. (2009). Hormesis defined. Ageing Research Reviews 7(1), 1-7.
21. MUSHAK, P. (2009). Ad hoc and fast forward: The science of hormesis growth and development. Environmental Health Perspectives 117, 1333-1338.
22. RAFTERY, A. E., MADIGAN, D. AND HOETING, J. A. (1997). Bayesian model averaging for linear regression models. Journal of the American Statistical Association 92, 179-191.
23. SCHABENBERGER, O. AND BIRCH, J. B. (2001). Statistical dose-response models with hormetic effects. Human and Ecological Risk Assessment: An International Journal 7(4), 891-908.
24. SIELKEN, R. L. AND STEVENSON, D. E. (1998). Some implications for quantitative risk assessment if hormesis exists. Human and Experimental Toxicology 17, 259-262.
25. THAYER, K. A., MELNICK, R., BURNS, K., DAVIS, D. AND HUFF, J. (2005). Fundamental flaws of hormesis for public health decisions. Environmental Health Perspectives 113(10), 1271-1276.
26. WAALKES, M. P., REHM, S., RIGGS, C. W., BARE, R. M., DEVOR, D. E., POIRIER, L. A., WENK, M. L., HENNEMAN, J. R. AND BALASCHAK, M. S. (1998). Cadmium carcinogenesis in male wistar [crl:(wi)br] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Research 48, 4656-4663.
27. ZAPPONI, G. A. AND MARCELLO, I. (2006). Low-dose risk, hormesis, analogical and logical thinking. Annals New York Academy of Sciences 1076, 839-857.
28. ZHANG, H., HOLDEN-WILTSE, J., WANG, J., LIANG, H. (2013). A strategy to model nonmonotonic dose-response curve and estimate ic50. PLoS ONE 8(8), e69301.